Femy stock news.

Find the latest dividend history for Femasys Inc. Common Stock (FEMY) at Nasdaq.com.Fintel. Fintel reports that on September 26, 2023, JonesTrading maintained coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,553.35% Upside As of ...The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.05 A.M. ET). Orchard Therapeutics plc ( ORTX) is up over 97% at $15.95. Grom Social Enterprises, Inc. ( GROM) is up over 27% at $2.23. Femasys Inc. ( FEMY) is up over 24% at $2.85.That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Institutional ...

Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.Oct 2, 2023 · One of the more recent movers in the stock market is Femasys Inc. (NASDAQ: FEMY). Shares of the biotech company’s shares have exploded from around $0.30 to highs of $4.75 within a matter of days. However, if you look at trading action in the stock market today, you’ll see that big gains can quickly turn into significant losses.

The consensus among . 3 Wall Street analysts covering (NASDAQ: FEMY) stock is to Strong Buy FEMY stock. Out of 3 analysts , 2 ( 66.67% ) are recommending FEMY as a Strong Buy, 1 ( 33.33% ) are recommending FEMY as a Buy, 0 ( 0% ) are recommending FEMY as a Hold, 0 ( 0% ) are recommending FEMY as a Sell, and 0 ( 0% ) are recommending FEMY as a ...

CHRS : 1.5900 (-0.62%) FEMY : 1.2200 (+0.83%) Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade Globe Newswire - Wed Jul 20, 2022. Webinar to be held Thursday, July 28th @ 10:30am EDT... Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 …Operating Status Active. Last Funding Type Post-IPO Debt. Legal Name Femasys Inc. Stock Symbol NASDAQ:FEMY. Company Type For Profit. Contact Email [email protected]. Phone Number 1 (770) 500-3910. Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel …High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years. Revenue vs Market: FEMY's revenue (64.4% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: FEMY's revenue (64.4% per year) is forecast to grow faster than 20% per year.

Femasys Stock Price, News & Analysis (NASDAQ:FEMY) $0.98 -0.03 (-2.98%) (As of 11/29/2023 ET) Compare Today's Range …

FEMY Femasys Inc Form 8-K - Current report. Pursuant to the Equity Distribution Agreement, sales of the Shares, will be made under the Company’s previously filed and effective Registration Statement on Form S-3 (File No. 333-266001) and an applicable prospectus supplement, by any method that is deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act ...

Kathy Lee-Sepsick. https://www.femasys.com. Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a ...That’s closing in on its daily average trading volume of about 210,000 shares. The company’s stock is also down 5.5% as of Tuesday morning. Adding to this, SGBXV stock is down 26.6%, while ...Femasys (FEMY) In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Femasys. The company’s shares closed last Wednesday at $1.11.Femasys Inc (NASDAQ: FEMY) shares surged after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a Find the latest news headlines from Femasys Inc. Common Stock (FEMY) at Nasdaq.com. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

FEMY - Femasys Inc Stock Price and Quote. Nov-23-23 03:38PM. 20 Countries with the Highest Teenage Pregnancy Rates. (Insider Monkey) Nov-15-23 08:30AM. PharmaCyte Biotech Acquires $5 Million Stake in Emerging Womens Health Innovator Femasys, Inc. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by ... Nov 28, 2023 · Femasys was founded in 2004 and went public in June 2021 at $13 per share, rising approximately $32M after fees and expenses. The Company then followed the general market downward for the next two... Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update. Get the latest Femasys Inc. (FEMY) stock news …The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...Negative. None. 10/25/2023 - 08:00 AM. ATLANTA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products ...Get Femasys Inc (FEMY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

View the latest Femasys Inc. (FEMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.AIM ImmunoTech Inc. 0.47. -0.002. -0.4237%. Get Femasys Inc (FEMY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest Femasys Inc. (FEMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Femasys Inc (NASDAQ: FEMY) shares surged after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a Fintel. Fintel reports that on September 26, 2023, JonesTrading maintained coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,553.35% Upside As of ...2 Okt 2023 ... Searching for the Perfect Broker? · Learn Stock Trading · Latest News · Before you trade, AskTraders.Femasys Inc (FEMY) $1.03 0.12 (13.19%) 13:00 EST FEMY Stock Quote Delayed 30 Minutes.Femasys (FEMY) In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Femasys. The company’s shares closed last Wednesday at $1.11.Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 128,310: Jun 29, 2023: 0.59%: 126,346: Vanguard Extended Market Index Fund: 8,823Jun 26, 2023 · - Pivotal clinical trial to begin in the third quarter of 2023 - ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical...

Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 …

Femasys Inc (FEMY) stock is trading at $1.10 as of 10:08 AM on Wednesday, Nov 15, an increase of $0.17, or 18.28% from the previous closing price of $0.93. The stock has traded between $1.05 and $1.25 so far today. Volume today is 2,748,419 compared to average volume of 3,456,068.

We would like to show you a description here but the site won’t allow us.Check the latest premarket stock price, chart and breaking news for FEMY. Quote; Premarket; Analysts; Insiders; Financials; Earnings; Filings; Profile; Historical; Performance » Buy FEMY Online Today!, find the best broker here. FEMY Premarket Chart. Track all markets on TradingView. FEMY Premarket News.Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved by -33.09% in ...Oct 4, 2023 · Publish : 04 Oct 2023, 07:17 PM Update : 04 Oct 2023, 07:17 PM. Femasys (NASDAQ: FEMY) stock is down 50% over night from highs. A reasonable bet would be that FEMY stock will continue to fall back to more reasonable levels. For, as far as we can see at least, this is a flurry of speculation producing far too much movement for the objective ... We would like to show you a description here but the site won’t allow us.FEMY | Complete Femasys Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. by Vandana Singh, Benzinga Editor. July 27, 2023 12:26 PM | 1 min read. Femasys Inc. FEMY. shares are trading higher after the company announced that the United States Patent and Trademark Office ...The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.05 A.M. ET). Orchard Therapeutics plc ( ORTX) is up over 97% at $15.95. Grom Social Enterprises, Inc. ( GROM) is up over 27% at $2.23. Femasys Inc. ( FEMY) is up over 24% at $2.85.

Asset Growth. -38.09%. Trailing 12-Months. This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K. Learn more about TipRanks Smart Score.Find the latest Femasys Inc. (FEMY) stock quote, history, news and other vital information to help you with your stock trading and investing. FEMY - Femasys Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... Femasys stock price target raised to $5.00 from $1.50 at Maxim Group MarketWatch. Friday, June 17, 2022. 07:45 AM ET.Price target. 8.50R USD +7.49 +741.58%. The 4 analysts offering 1 year price forecasts for Femasys Inc. have a max estimate of 12.00 and a min estimate of 5.00.Instagram:https://instagram. nasdaq hqypremarket robinhoodvalue of a 1976 quarterbest texas dental insurance Nov 17, 2023 · The latest Femasys stock prices, stock quotes, news, and FEMY history to help you invest and trade smarter. ... Femasys Inc Registered Shs Stock , FEMY. 0.95-0.01 -1.53% ... This trend is expected to have continued in the to-be-reported quarter. The Zacks Consensus Estimate for Femasys’ sales in the third quarter of 2023 is pegged at $0.4 million. However, sales in ... how to file taxes as a day traderhow to buy aramco shares Femasys Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time FEMY stock price.Femasys (FEMY) shares fell 13% premarket on Wednesday after the biomedical company announced an offering to raise $3.9M.The company is selling 3,196,722 shares of common stock (or... meta options Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.These Healthcare stocks are trading higher: -Femasys Inc ( FEMY) stock is trading at $3.30, an increase of $1.78, or 108.59%, on high volume. Femasys Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.50. -Evoke Pharma Inc ( EVOK) …